News – 2025
June 16, 2025
Tiny, zapping implant gives spinal cord injury survivors new hope
June 11, 2025
How UT Dallas researchers are helping spinal injury patients reclaim their lives
With a tablet propped up in front of him and a joystick-like device in hand, Marshall Bell looks like he’s playing a video game. But it’s actually physical therapy — powered by innovative, Texas-developed technology that’s changing his life.
“I can officially shampoo my hair with my injured arm,” said Bell, 35, of Arlington, with a smile. “It might take a while, but I am just ecstatic to be able to get it to touch my —” he said, moving his hand to his head to demonstrate.
May 7, 2025
DARPA-Funded Research Develops Novel Technology to Combat Treatment-Resistant PTSD
Groundbreaking research has revealed a new method of potentially eliminating hard-to-treat post-traumatic stress disorder (PTSD) diagnoses in patients by employing a novel kind of therapy: stimulation of the vagus nerve.
May 5, 2025
Vagus nerve stimulation provides long-term benefits for PTSD patients in clinical study
In a first-of-its-kind clinical study, scientists at the University of Texas at Dallas and Baylor University Medical Center have shown that patients with treatment-resistant PTSD were symptom-free up to six months after completing traditional therapy paired with vagus nerve stimulation (VNS).
April 30, 2025
Study: PTSD Patients Show Long-Term Benefits with Vagus Nerve Stimulation
In a first-of-its-kind clinical study, scientists at The University of Texas at Dallas and Baylor University Medical Center showed that patients with treatment-resistant PTSD were symptom-free up to six months after completing traditional therapy paired with vagus nerve stimulation (VNS).
May 6, 2025
Vagus Nerve Breakthrough Erases PTSD
The vagus nerve plays a crucial (if underrated) role in facilitating how the brain communicates with the rest of the body. It helps regulate the body’s immune response and mental health functions. While how it works remains a little murky, research into gut-derived molecules and vagal pathways has the potential to identify potential targets for microbiome-based therapies, such as vagus nerve stimulation (VNS).
